---
title: Investment Thesis
description: Why Sarkome is a unique opportunity.
---

## Thesis

- **Monogenic Driver**: Single fusion protein reduces biological complexity.
- **Validated Modality**: Targeted Protein Degradation (PROTACs).
- **Capital Efficient**: Virtual model eliminates fixed lab costs.
